Plasma glucagon-like peptide-2 in cats with chronic enteropathies. [PDF]
Jugan MC +5 more
europepmc +1 more source
Commentary: a comparison of glucagon‐like peptides 1 and 2 [PDF]
Moran, G.W., Lal, S., McLaughlin, J.T.
openaire +3 more sources
Glucagon-Like Peptide-2 as a Potential Biomarker for Nonalcoholic Fatty Liver Disease in Children with Obesity: Preliminary Assessment of Metabolic Associations and Underlying Mechanisms. [PDF]
Zhang SJ +5 more
europepmc +1 more source
Glucagon-Like Peptide 21 [PDF]
openaire +1 more source
Glucagon-like Peptide-2 Acts Partially Through Central GLP-2R and MC4R in Mobilizing Stored Lipids from the Intestine. [PDF]
Mukherjee K +3 more
europepmc +1 more source
Effect of teduglutide, a glucagon-like peptide-2 analog, in eosinophilic enterocolitis: a case report. [PDF]
Ogawa S +7 more
europepmc +1 more source
Development of a Mechanism of Action-Reflective Cell-Based Reporter Gene Assay for Measuring Bioactivities of Therapeutic Glucagon-like Peptide-2 Analogues. [PDF]
Zhang X, Li C, Deng Z, Liang C, Li J.
europepmc +1 more source
The Possible Involvement of Glucagon-like Peptide-2 in the Regulation of Food Intake through the Gut-Brain Axis. [PDF]
Baccari MC, Vannucchi MG, Idrizaj E.
europepmc +1 more source
Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: An open-label phase 1 and 2 metabolic balance trial. [PDF]
Eliasson J +5 more
europepmc +1 more source
Novel homozygous nonsense mutation in glucagon-like peptide-2 receptor gene resulting in severe human illness. [PDF]
Jaramishian C +3 more
europepmc +1 more source

